Test Bank: Prescriber's Guide - Stahl's Essential
Psychopharmacology 7th Edition Questions And
Well Graded Solutions With Rationales Updated
2026-2027
,Test Bank: Prescriber's Guide - Stahl's Essential
Psychopharmacology 7th Edition Questions And
Well Graded Solutions With Rationales Updated
2026-2027
Table of Contents
Chapter Title Questions
1 The Neuroscience of Psychopharmacology 1-25
2 Pharmacokinetics and Pharmacodynamics 26-50
3 Antidepressants 51-75
4 Antipsychotics 76-100
5 Mood Stabilizers 101-125
6 Anxiolytics and Hypnotics 126-150
7 Stimulants and Wakefulness-Promoting Agents 151-175
8 Cognitive Enhancers and Anti-Dementia Agents 176-200
9 Substance Use Disorder Treatments 201-225
10 Antiepileptics in Psychiatry 226-250
11 Alpha-2 Agonists and Beta-Blockers 251-275
12 Special Populations (Pediatric, Geriatric, Pregnancy) 276-300
,Chapter 1: The Neuroscience of Psychopharmacology
Question 1: A psychiatric nurse is teaching a patient about the basic structure of
neurons. Which statement accurately describes the function of the axon hillock?
A) It receives incoming signals from other neurons through dendritic spines
B) It is the site where the action potential is generated before transmission down the
axon
C) It stores neurotransmitters in vesicles for release into the synaptic cleft
D) It contains the genetic material and metabolic machinery of the neuron
Answer: B
Rationale: The axon hillock is the specialized region where the cell body meets the
axon. It serves as the integration zone where excitatory and inhibitory inputs are
summated. When the membrane potential reaches threshold, an action potential is
initiated at this site and propagates down the axon. Option A describes dendrites,
option C describes synaptic vesicles, and option D describes the cell body (soma).
Question 2: A patient asks the psychiatrist how medications can affect brain
function. The physician explains that psychotropic drugs primarily exert their effects
at which location?
A) The cell nucleus where DNA transcription occurs
B) The myelin sheath surrounding the axon
C) The synapse, particularly at receptors and transporters
D) The blood-brain barrier endothelial cells
Answer: C
Rationale: Most psychotropic medications act at the synapse by altering
neurotransmitter availability, receptor binding, or transporter function. The synapse is
the primary site of communication between neurons and represents the main target for
psychopharmacological intervention. The nucleus (A) is targeted by some agents but
not most psychotropics. Myelin (B) is affected in demyelinating diseases but not by
typical psychotropics. The blood-brain barrier (D) is relevant for drug penetration but is
not the primary site of drug action.
Question 3: A medical student is studying neurotransmitter synthesis. Which
precursor amino acid is correctly paired with its neurotransmitter product?
A) Tryptophan → Dopamine
B) Tyrosine → Serotonin
, C) Glutamine → GABA
D) Tyrosine → Norepinephrine
Answer: D
Rationale: Tyrosine is the precursor for the catecholamine neurotransmitters including
dopamine, norepinephrine, and epinephrine. Tryptophan is the precursor for serotonin
(A and B are reversed). Glutamine is a precursor for glutamate, not GABA (C is
incorrect).
Question 4: A researcher is investigating receptor subtypes. Which statement
correctly describes the difference between ionotropic and metabotropic receptors?
A) Ionotropic receptors are slower and use second messengers; metabotropic receptors
are fast and directly open ion channels
B) Ionotropic receptors are fast and directly open ion channels; metabotropic receptors
are slower and use second messenger systems
C) Both receptor types function identically but are found in different brain regions
D) Ionotropic receptors are exclusively inhibitory, while metabotropic receptors are
exclusively excitatory
Answer: B
Rationale: Ionotropic receptors are ligand-gated ion channels that produce rapid,
direct effects by opening ion channels upon neurotransmitter binding. Metabotropic
receptors are G-protein coupled receptors that act through second messenger cascades,
producing slower but longer-lasting effects. The descriptions in A are reversed. C is
incorrect as they function differently. D is incorrect as both receptor types can be
excitatory or inhibitory depending on the ion involved.
Question 5: A patient with schizophrenia is started on an antipsychotic medication.
The drug's therapeutic effect is primarily attributed to blockade of which receptor?
A) Serotonin 5-HT2A receptors
B) Dopamine D2 receptors
C) Muscarinic acetylcholine receptors
D) Histamine H1 receptors
Answer: B
Rationale: The therapeutic efficacy of antipsychotic medications in treating positive
symptoms of schizophrenia is primarily attributed to dopamine D2 receptor blockade
in the mesolimbic pathway. While 5-HT2A antagonism (A) contributes to the efficacy of
Psychopharmacology 7th Edition Questions And
Well Graded Solutions With Rationales Updated
2026-2027
,Test Bank: Prescriber's Guide - Stahl's Essential
Psychopharmacology 7th Edition Questions And
Well Graded Solutions With Rationales Updated
2026-2027
Table of Contents
Chapter Title Questions
1 The Neuroscience of Psychopharmacology 1-25
2 Pharmacokinetics and Pharmacodynamics 26-50
3 Antidepressants 51-75
4 Antipsychotics 76-100
5 Mood Stabilizers 101-125
6 Anxiolytics and Hypnotics 126-150
7 Stimulants and Wakefulness-Promoting Agents 151-175
8 Cognitive Enhancers and Anti-Dementia Agents 176-200
9 Substance Use Disorder Treatments 201-225
10 Antiepileptics in Psychiatry 226-250
11 Alpha-2 Agonists and Beta-Blockers 251-275
12 Special Populations (Pediatric, Geriatric, Pregnancy) 276-300
,Chapter 1: The Neuroscience of Psychopharmacology
Question 1: A psychiatric nurse is teaching a patient about the basic structure of
neurons. Which statement accurately describes the function of the axon hillock?
A) It receives incoming signals from other neurons through dendritic spines
B) It is the site where the action potential is generated before transmission down the
axon
C) It stores neurotransmitters in vesicles for release into the synaptic cleft
D) It contains the genetic material and metabolic machinery of the neuron
Answer: B
Rationale: The axon hillock is the specialized region where the cell body meets the
axon. It serves as the integration zone where excitatory and inhibitory inputs are
summated. When the membrane potential reaches threshold, an action potential is
initiated at this site and propagates down the axon. Option A describes dendrites,
option C describes synaptic vesicles, and option D describes the cell body (soma).
Question 2: A patient asks the psychiatrist how medications can affect brain
function. The physician explains that psychotropic drugs primarily exert their effects
at which location?
A) The cell nucleus where DNA transcription occurs
B) The myelin sheath surrounding the axon
C) The synapse, particularly at receptors and transporters
D) The blood-brain barrier endothelial cells
Answer: C
Rationale: Most psychotropic medications act at the synapse by altering
neurotransmitter availability, receptor binding, or transporter function. The synapse is
the primary site of communication between neurons and represents the main target for
psychopharmacological intervention. The nucleus (A) is targeted by some agents but
not most psychotropics. Myelin (B) is affected in demyelinating diseases but not by
typical psychotropics. The blood-brain barrier (D) is relevant for drug penetration but is
not the primary site of drug action.
Question 3: A medical student is studying neurotransmitter synthesis. Which
precursor amino acid is correctly paired with its neurotransmitter product?
A) Tryptophan → Dopamine
B) Tyrosine → Serotonin
, C) Glutamine → GABA
D) Tyrosine → Norepinephrine
Answer: D
Rationale: Tyrosine is the precursor for the catecholamine neurotransmitters including
dopamine, norepinephrine, and epinephrine. Tryptophan is the precursor for serotonin
(A and B are reversed). Glutamine is a precursor for glutamate, not GABA (C is
incorrect).
Question 4: A researcher is investigating receptor subtypes. Which statement
correctly describes the difference between ionotropic and metabotropic receptors?
A) Ionotropic receptors are slower and use second messengers; metabotropic receptors
are fast and directly open ion channels
B) Ionotropic receptors are fast and directly open ion channels; metabotropic receptors
are slower and use second messenger systems
C) Both receptor types function identically but are found in different brain regions
D) Ionotropic receptors are exclusively inhibitory, while metabotropic receptors are
exclusively excitatory
Answer: B
Rationale: Ionotropic receptors are ligand-gated ion channels that produce rapid,
direct effects by opening ion channels upon neurotransmitter binding. Metabotropic
receptors are G-protein coupled receptors that act through second messenger cascades,
producing slower but longer-lasting effects. The descriptions in A are reversed. C is
incorrect as they function differently. D is incorrect as both receptor types can be
excitatory or inhibitory depending on the ion involved.
Question 5: A patient with schizophrenia is started on an antipsychotic medication.
The drug's therapeutic effect is primarily attributed to blockade of which receptor?
A) Serotonin 5-HT2A receptors
B) Dopamine D2 receptors
C) Muscarinic acetylcholine receptors
D) Histamine H1 receptors
Answer: B
Rationale: The therapeutic efficacy of antipsychotic medications in treating positive
symptoms of schizophrenia is primarily attributed to dopamine D2 receptor blockade
in the mesolimbic pathway. While 5-HT2A antagonism (A) contributes to the efficacy of
